

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.44518974 |
| 2 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.89570228 |
| 3 | interkinetic nuclear migration (GO:0022027) | 4.88414358 |
| 4 | establishment of protein localization to Golgi (GO:0072600) | 4.87571019 |
| 5 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 4.85219128 |
| 6 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 4.85219128 |
| 7 | regulation of translation, ncRNA-mediated (GO:0045974) | 4.85219128 |
| 8 | snRNA transcription (GO:0009301) | 4.80136624 |
| 9 | regulation of establishment of cell polarity (GO:2000114) | 4.75307660 |
| 10 | DNA deamination (GO:0045006) | 4.61217568 |
| 11 | lipid translocation (GO:0034204) | 4.28627660 |
| 12 | phospholipid translocation (GO:0045332) | 4.28627660 |
| 13 | negative regulation of protein localization to cell surface (GO:2000009) | 4.21384141 |
| 14 | protein K48-linked deubiquitination (GO:0071108) | 4.19787953 |
| 15 | cytoplasmic mRNA processing body assembly (GO:0033962) | 4.19180231 |
| 16 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.16108946 |
| 17 | neural tube formation (GO:0001841) | 4.08602840 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.03084519 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.03084519 |
| 20 | tryptophan catabolic process (GO:0006569) | 4.03084519 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.95787829 |
| 22 | cellular response to ethanol (GO:0071361) | 3.95053791 |
| 23 | kynurenine metabolic process (GO:0070189) | 3.95032822 |
| 24 | response to interferon-beta (GO:0035456) | 3.89643044 |
| 25 | signal peptide processing (GO:0006465) | 3.88751856 |
| 26 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.86863904 |
| 27 | regulation of hippo signaling (GO:0035330) | 3.85865283 |
| 28 | sequestering of actin monomers (GO:0042989) | 3.83569268 |
| 29 | protein targeting to lysosome (GO:0006622) | 3.79683622 |
| 30 | establishment of protein localization to vacuole (GO:0072666) | 3.79683622 |
| 31 | protein targeting to vacuole (GO:0006623) | 3.79683622 |
| 32 | negative regulation of sodium ion transport (GO:0010766) | 3.75414520 |
| 33 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.68979165 |
| 34 | daunorubicin metabolic process (GO:0044597) | 3.63788345 |
| 35 | polyketide metabolic process (GO:0030638) | 3.63788345 |
| 36 | doxorubicin metabolic process (GO:0044598) | 3.63788345 |
| 37 | indolalkylamine metabolic process (GO:0006586) | 3.60468841 |
| 38 | oxidative demethylation (GO:0070989) | 3.60377223 |
| 39 | pericardium development (GO:0060039) | 3.45909060 |
| 40 | tryptophan metabolic process (GO:0006568) | 3.45390138 |
| 41 | cellular response to interferon-beta (GO:0035458) | 3.41213861 |
| 42 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.39508842 |
| 43 | regulation of gene silencing by miRNA (GO:0060964) | 3.39508842 |
| 44 | regulation of gene silencing by RNA (GO:0060966) | 3.39508842 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.38370809 |
| 46 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.35796623 |
| 47 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.31423824 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.30929519 |
| 49 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30775193 |
| 50 | cardiovascular system development (GO:0072358) | 3.30134274 |
| 51 | histone H3-K4 trimethylation (GO:0080182) | 3.28116278 |
| 52 | flavonoid metabolic process (GO:0009812) | 3.25408164 |
| 53 | protein K63-linked deubiquitination (GO:0070536) | 3.23781731 |
| 54 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.23212002 |
| 55 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.23212002 |
| 56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16893751 |
| 57 | viral transcription (GO:0019083) | 3.15670554 |
| 58 | translational termination (GO:0006415) | 3.15329556 |
| 59 | * endosome to melanosome transport (GO:0035646) | 3.11881930 |
| 60 | * endosome to pigment granule transport (GO:0043485) | 3.11881930 |
| 61 | nucleus localization (GO:0051647) | 3.10475842 |
| 62 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.09649066 |
| 63 | protein K11-linked deubiquitination (GO:0035871) | 3.06119055 |
| 64 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.06028861 |
| 65 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04574162 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04574162 |
| 67 | corticosteroid receptor signaling pathway (GO:0031958) | 3.02453535 |
| 68 | endocardial cushion development (GO:0003197) | 3.02420928 |
| 69 | maturation of SSU-rRNA (GO:0030490) | 3.02241606 |
| 70 | purine-containing compound salvage (GO:0043101) | 3.01965892 |
| 71 | cellular response to type I interferon (GO:0071357) | 3.00522769 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.00522769 |
| 73 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.99727139 |
| 74 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.98575656 |
| 75 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.98221629 |
| 76 | regulation of sarcomere organization (GO:0060297) | 2.97605730 |
| 77 | protein targeting to Golgi (GO:0000042) | 2.97438443 |
| 78 | proteasome assembly (GO:0043248) | 2.94175095 |
| 79 | L-fucose catabolic process (GO:0042355) | 2.93482109 |
| 80 | fucose catabolic process (GO:0019317) | 2.93482109 |
| 81 | L-fucose metabolic process (GO:0042354) | 2.93482109 |
| 82 | microtubule anchoring (GO:0034453) | 2.93184805 |
| 83 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.92862316 |
| 84 | behavioral response to nicotine (GO:0035095) | 2.92726826 |
| 85 | translational elongation (GO:0006414) | 2.92632602 |
| 86 | response to interferon-alpha (GO:0035455) | 2.92490593 |
| 87 | response to type I interferon (GO:0034340) | 2.92455162 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.92252821 |
| 89 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.92066318 |
| 90 | cytochrome complex assembly (GO:0017004) | 2.91647446 |
| 91 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.89840634 |
| 92 | platelet dense granule organization (GO:0060155) | 2.88197262 |
| 93 | protein deneddylation (GO:0000338) | 2.87805740 |
| 94 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.87086314 |
| 95 | telomere maintenance via recombination (GO:0000722) | 2.85425627 |
| 96 | sulfation (GO:0051923) | 2.83707290 |
| 97 | DNA strand elongation (GO:0022616) | 2.83522761 |
| 98 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.82657145 |
| 99 | peptidyl-lysine methylation (GO:0018022) | 2.82430982 |
| 100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.82407279 |
| 101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.82407279 |
| 102 | B cell mediated immunity (GO:0019724) | 2.80910002 |
| 103 | thyroid hormone metabolic process (GO:0042403) | 2.79620273 |
| 104 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.79513666 |
| 105 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.79397120 |
| 106 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.79397120 |
| 107 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.79397120 |
| 108 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.78493618 |
| 109 | cotranslational protein targeting to membrane (GO:0006613) | 2.78038457 |
| 110 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.77654466 |
| 111 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76328916 |
| 112 | photoreceptor cell maintenance (GO:0045494) | 2.75483946 |
| 113 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.73161756 |
| 114 | protein targeting to ER (GO:0045047) | 2.72189092 |
| 115 | pseudouridine synthesis (GO:0001522) | 2.71852534 |
| 116 | negative regulation of viral genome replication (GO:0045071) | 2.70968061 |
| 117 | respiratory chain complex IV assembly (GO:0008535) | 2.70466770 |
| 118 | reflex (GO:0060004) | 2.70462802 |
| 119 | cellular response to sterol (GO:0036315) | 2.70457853 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70437296 |
| 121 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70171155 |
| 122 | histone H3-K9 methylation (GO:0051567) | 2.68615371 |
| 123 | cullin deneddylation (GO:0010388) | 2.67438537 |
| 124 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.67050153 |
| 125 | detection of light stimulus involved in visual perception (GO:0050908) | 2.67050153 |
| 126 | negative regulation of phagocytosis (GO:0050765) | 2.66480935 |
| 127 | cellular response to zinc ion (GO:0071294) | 2.66189968 |
| 128 | defense response to protozoan (GO:0042832) | 2.66033874 |
| 129 | indole-containing compound metabolic process (GO:0042430) | 2.65809443 |
| 130 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.64060773 |
| 131 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.63258078 |
| 132 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.63258078 |
| 133 | formation of translation preinitiation complex (GO:0001731) | 2.62302333 |
| 134 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.62067394 |
| 135 | protein localization to endoplasmic reticulum (GO:0070972) | 2.62017748 |
| 136 | negative regulation of ligase activity (GO:0051352) | 2.60574198 |
| 137 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60574198 |
| 138 | limb development (GO:0060173) | 2.60277321 |
| 139 | appendage development (GO:0048736) | 2.60277321 |
| 140 | central nervous system neuron axonogenesis (GO:0021955) | 2.60238918 |
| 141 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58902034 |
| 142 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.58805882 |
| 143 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.58169607 |
| 144 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.57997148 |
| 145 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.56970128 |
| 146 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.56834966 |
| 147 | mitotic recombination (GO:0006312) | 2.56749453 |
| 148 | NAD biosynthetic process (GO:0009435) | 2.56152099 |
| 149 | kinetochore organization (GO:0051383) | 2.55673083 |
| 150 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.55622009 |
| 151 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.54675577 |
| 152 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.54529941 |
| 153 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.54345072 |
| 154 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.54284067 |
| 155 | reactive oxygen species biosynthetic process (GO:1903409) | 2.54182135 |
| 156 | response to host immune response (GO:0052572) | 2.53735569 |
| 157 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.53735569 |
| 158 | viral life cycle (GO:0019058) | 2.52447961 |
| 159 | telomere maintenance via telomere lengthening (GO:0010833) | 2.52426339 |
| 160 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51844015 |
| 161 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51844015 |
| 162 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51844015 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.51844015 |
| 164 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51844015 |
| 165 | modulation by symbiont of host defense response (GO:0052031) | 2.51844015 |
| 166 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.50093880 |
| 167 | peptidyl-lysine trimethylation (GO:0018023) | 2.49033387 |
| 168 | cellular protein complex disassembly (GO:0043624) | 2.48788231 |
| 169 | kinetochore assembly (GO:0051382) | 2.47925647 |
| 170 | serotonin metabolic process (GO:0042428) | 2.47631944 |
| 171 | response to peptidoglycan (GO:0032494) | 2.46570937 |
| 172 | negative regulation of neurotransmitter transport (GO:0051589) | 2.46418013 |
| 173 | ribosomal small subunit biogenesis (GO:0042274) | 2.46230996 |
| 174 | ribosomal large subunit biogenesis (GO:0042273) | 2.45042988 |
| 175 | termination of RNA polymerase III transcription (GO:0006386) | 2.44610196 |
| 176 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.44610196 |
| 177 | translational initiation (GO:0006413) | 2.44489634 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44269835 |
| 179 | translation (GO:0006412) | 2.43918006 |
| 180 | striated muscle atrophy (GO:0014891) | 2.43606674 |
| 181 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.42544321 |
| 182 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.42283113 |
| 183 | cilium organization (GO:0044782) | 2.40579475 |
| 184 | protein localization to Golgi apparatus (GO:0034067) | 2.40096516 |
| 185 | gamma-aminobutyric acid transport (GO:0015812) | 2.39507752 |
| 186 | cilium assembly (GO:0042384) | 2.39061343 |
| 187 | protein localization to vacuole (GO:0072665) | 2.37962634 |
| 188 | protein localization to lysosome (GO:0061462) | 2.37962634 |
| 189 | neuronal action potential (GO:0019228) | 2.37310912 |
| 190 | negative regulation of mast cell activation (GO:0033004) | 2.37106907 |
| 191 | histone lysine methylation (GO:0034968) | 2.36044048 |
| 192 | regulation of respiratory system process (GO:0044065) | 2.34642454 |
| 193 | regulation of membrane lipid distribution (GO:0097035) | 2.32675170 |
| 194 | replicative senescence (GO:0090399) | 2.30150825 |
| 195 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.30113135 |
| 196 | cilium morphogenesis (GO:0060271) | 2.30015259 |
| 197 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.29808508 |
| 198 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.29808508 |
| 199 | primary amino compound metabolic process (GO:1901160) | 2.29375128 |
| 200 | histone-serine phosphorylation (GO:0035404) | 2.28940146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.26112663 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.99416184 |
| 3 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.70762766 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.67684905 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56445376 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.34903155 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.31455828 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.25899480 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.18678135 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.18237879 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.99004678 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.96614451 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.95945074 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.92329711 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.86920754 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.83460781 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.74185291 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72320218 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.67611789 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.60598354 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52504021 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.51562177 |
| 23 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.46721870 |
| 24 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46378010 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44644478 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.41817277 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.41408629 |
| 28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.40433093 |
| 29 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.37523871 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.36663424 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32755899 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.32715238 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.32679862 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31593424 |
| 35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.27432424 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27035227 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.19350453 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15245437 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.14568730 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.13398706 |
| 41 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.13392859 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.13216379 |
| 43 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.12979641 |
| 44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.11374556 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.09819759 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.07388687 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.04870704 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 2.03466535 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 2.01675612 |
| 50 | EWS_26573619_Chip-Seq_HEK293_Human | 2.01620829 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01400512 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01114338 |
| 53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.99256799 |
| 54 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.98236467 |
| 55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.97143347 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96844889 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.95640055 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.95002247 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94864317 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.93943618 |
| 61 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93393729 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.91695604 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91598057 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89965028 |
| 65 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88881363 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.88282652 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.88055436 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.86923118 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86130966 |
| 70 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.85220849 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84288413 |
| 72 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82657733 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.79121798 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76148484 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.75588542 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.74790253 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74575673 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.74158062 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.72093678 |
| 80 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.72044715 |
| 81 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71854935 |
| 82 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.71426548 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.70640071 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70501563 |
| 85 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68218493 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.68055635 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68035221 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.65520927 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.65301263 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.62684716 |
| 91 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62678239 |
| 92 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.62381415 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.60282585 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60064207 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.59784529 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.59784529 |
| 97 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58044952 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.55883826 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55881947 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55702282 |
| 101 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.54465766 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.54325569 |
| 103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51658902 |
| 104 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48709674 |
| 105 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.47473242 |
| 106 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.47473242 |
| 107 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45968930 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45624157 |
| 109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.45451819 |
| 110 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45019123 |
| 111 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44038765 |
| 112 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41933391 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41025980 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40712721 |
| 115 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39780945 |
| 116 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39503322 |
| 117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39297499 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 1.38220028 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37536632 |
| 120 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37428067 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35656721 |
| 122 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35401394 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34126647 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33888535 |
| 125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31231382 |
| 126 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31183632 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.30002005 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29194347 |
| 129 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.29169545 |
| 130 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29027291 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28362489 |
| 132 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28289980 |
| 133 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.28007821 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25216117 |
| 135 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25005843 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23777310 |
| 137 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23302548 |
| 138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22228429 |
| 139 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22066719 |
| 140 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.21910616 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21697168 |
| 142 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.21453463 |
| 143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21233969 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21233969 |
| 145 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20718467 |
| 146 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20533859 |
| 147 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20358176 |
| 148 | KDM2B_26808549_Chip-Seq_REH_Human | 1.20054375 |
| 149 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19837738 |
| 150 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18666441 |
| 151 | MYC_22102868_ChIP-Seq_BL_Human | 1.18040867 |
| 152 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16830615 |
| 153 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16493030 |
| 154 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16470981 |
| 155 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15660898 |
| 156 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15518962 |
| 157 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14002079 |
| 158 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11523042 |
| 159 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10204414 |
| 160 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09461155 |
| 161 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09349253 |
| 162 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09094134 |
| 163 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08615835 |
| 164 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08429861 |
| 165 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07038557 |
| 166 | AR_19668381_ChIP-Seq_PC3_Human | 1.06974007 |
| 167 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06449667 |
| 168 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05565082 |
| 169 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05438296 |
| 170 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05338115 |
| 171 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05299961 |
| 172 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.04607117 |
| 173 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04098476 |
| 174 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03644406 |
| 175 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03446010 |
| 176 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02783353 |
| 177 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02432094 |
| 178 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02231762 |
| 179 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02228803 |
| 180 | MYB_26560356_Chip-Seq_TH1_Human | 1.01752307 |
| 181 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01677786 |
| 182 | MAF_26560356_Chip-Seq_TH1_Human | 1.01321944 |
| 183 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01122445 |
| 184 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00624711 |
| 185 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00235896 |
| 186 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99954057 |
| 187 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99588915 |
| 188 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99467763 |
| 189 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98859717 |
| 190 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98669854 |
| 191 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98040139 |
| 192 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.97987042 |
| 193 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97331070 |
| 194 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96355637 |
| 195 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94959411 |
| 196 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94082024 |
| 197 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92992256 |
| 198 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91825176 |
| 199 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.87172767 |
| 200 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86547803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.07458245 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.09630926 |
| 3 | MP0003195_calcinosis | 3.57960463 |
| 4 | MP0009785_altered_susceptibility_to | 3.56629393 |
| 5 | MP0004043_abnormal_pH_regulation | 2.98949367 |
| 6 | MP0003724_increased_susceptibility_to | 2.96864556 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.83465034 |
| 8 | MP0008961_abnormal_basal_metabolism | 2.77142009 |
| 9 | MP0003436_decreased_susceptibility_to | 2.75431729 |
| 10 | MP0005671_abnormal_response_to | 2.73427810 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.60906595 |
| 12 | MP0000427_abnormal_hair_cycle | 2.53859627 |
| 13 | MP0000383_abnormal_hair_follicle | 2.52140838 |
| 14 | MP0009046_muscle_twitch | 2.51762091 |
| 15 | MP0005025_abnormal_response_to | 2.45015147 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.44708694 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.35987413 |
| 18 | MP0002009_preneoplasia | 2.26745112 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.24464489 |
| 20 | MP0000685_abnormal_immune_system | 2.23883648 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.18749769 |
| 22 | MP0002419_abnormal_innate_immunity | 2.17964048 |
| 23 | MP0008058_abnormal_DNA_repair | 2.16017445 |
| 24 | MP0003693_abnormal_embryo_hatching | 2.14317085 |
| 25 | MP0000015_abnormal_ear_pigmentation | 2.11601909 |
| 26 | MP0001800_abnormal_humoral_immune | 2.11454195 |
| 27 | MP0001819_abnormal_immune_cell | 2.10021549 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.08305014 |
| 29 | MP0009379_abnormal_foot_pigmentation | 2.05208388 |
| 30 | MP0004147_increased_porphyrin_level | 2.03080364 |
| 31 | MP0001545_abnormal_hematopoietic_system | 2.00372206 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 2.00372206 |
| 33 | MP0002398_abnormal_bone_marrow | 1.99718960 |
| 34 | MP0002723_abnormal_immune_serum | 1.94297145 |
| 35 | MP0005387_immune_system_phenotype | 1.90981716 |
| 36 | MP0001790_abnormal_immune_system | 1.90981716 |
| 37 | MP0003787_abnormal_imprinting | 1.86910186 |
| 38 | MP0004130_abnormal_muscle_cell | 1.85198679 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 1.83255615 |
| 40 | MP0006292_abnormal_olfactory_placode | 1.82909057 |
| 41 | MP0003186_abnormal_redox_activity | 1.82016881 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.80795623 |
| 43 | MP0003045_fibrosis | 1.79044425 |
| 44 | MP0001853_heart_inflammation | 1.77866204 |
| 45 | MP0004510_myositis | 1.77417827 |
| 46 | MP0000716_abnormal_immune_system | 1.76253343 |
| 47 | MP0000858_altered_metastatic_potential | 1.67641966 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.66156103 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.64829297 |
| 50 | MP0002429_abnormal_blood_cell | 1.63050912 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.60903358 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.60004576 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.59912481 |
| 54 | MP0000490_abnormal_crypts_of | 1.56798714 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.56768164 |
| 56 | MP0003077_abnormal_cell_cycle | 1.56245633 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.54434783 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.54397384 |
| 59 | MP0008007_abnormal_cellular_replicative | 1.54172924 |
| 60 | MP0002405_respiratory_system_inflammati | 1.53304703 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.53111659 |
| 62 | MP0004924_abnormal_behavior | 1.53029544 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.53029544 |
| 64 | MP0004142_abnormal_muscle_tone | 1.52793477 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.52409310 |
| 66 | MP0002722_abnormal_immune_system | 1.50683990 |
| 67 | MP0003646_muscle_fatigue | 1.47356779 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.47320459 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.43827274 |
| 70 | MP0003136_yellow_coat_color | 1.42064485 |
| 71 | MP0000343_altered_response_to | 1.41666396 |
| 72 | MP0006082_CNS_inflammation | 1.41504358 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.40705658 |
| 74 | MP0005266_abnormal_metabolism | 1.40688068 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.40221140 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.39175906 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.38136719 |
| 78 | MP0001188_hyperpigmentation | 1.37801880 |
| 79 | MP0000681_abnormal_thyroid_gland | 1.36139031 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 1.35927010 |
| 81 | MP0005187_abnormal_penis_morphology | 1.35171757 |
| 82 | MP0009745_abnormal_behavioral_response | 1.34455184 |
| 83 | MP0001486_abnormal_startle_reflex | 1.34291491 |
| 84 | MP0003172_abnormal_lysosome_physiology | 1.32728858 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 1.32680088 |
| 86 | MP0002928_abnormal_bile_duct | 1.31861346 |
| 87 | MP0003111_abnormal_nucleus_morphology | 1.30476786 |
| 88 | MP0002168_other_aberrant_phenotype | 1.30407093 |
| 89 | MP0009764_decreased_sensitivity_to | 1.29703876 |
| 90 | MP0008877_abnormal_DNA_methylation | 1.28792320 |
| 91 | MP0005253_abnormal_eye_physiology | 1.27890771 |
| 92 | MP0002006_tumorigenesis | 1.27797631 |
| 93 | MP0003786_premature_aging | 1.25914142 |
| 94 | MP0002067_abnormal_sensory_capabilities | 1.24424764 |
| 95 | MP0002736_abnormal_nociception_after | 1.24177108 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 1.24175387 |
| 97 | MP0005646_abnormal_pituitary_gland | 1.22991116 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 1.22578958 |
| 99 | MP0003315_abnormal_perineum_morphology | 1.20633275 |
| 100 | MP0009115_abnormal_fat_cell | 1.19182486 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 1.18349840 |
| 102 | MP0000703_abnormal_thymus_morphology | 1.17765757 |
| 103 | MP0005310_abnormal_salivary_gland | 1.17220336 |
| 104 | MP0002638_abnormal_pupillary_reflex | 1.16832470 |
| 105 | MP0003828_pulmonary_edema | 1.15962976 |
| 106 | MP0008469_abnormal_protein_level | 1.15679588 |
| 107 | MP0002064_seizures | 1.15676182 |
| 108 | MP0001533_abnormal_skeleton_physiology | 1.15462854 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 1.15069554 |
| 110 | MP0005171_absent_coat_pigmentation | 1.14570452 |
| 111 | MP0003252_abnormal_bile_duct | 1.13626830 |
| 112 | MP0003123_paternal_imprinting | 1.11330364 |
| 113 | MP0000538_abnormal_urinary_bladder | 1.11131140 |
| 114 | MP0003183_abnormal_peptide_metabolism | 1.11049311 |
| 115 | MP0000778_abnormal_nervous_system | 1.10610514 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 1.09393836 |
| 117 | MP0002572_abnormal_emotion/affect_behav | 1.07221901 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 1.04463250 |
| 119 | MP0002132_abnormal_respiratory_system | 1.02694311 |
| 120 | MP0002933_joint_inflammation | 1.02623677 |
| 121 | MP0002557_abnormal_social/conspecific_i | 1.00915201 |
| 122 | MP0002938_white_spotting | 1.00886479 |
| 123 | MP0002272_abnormal_nervous_system | 1.00511472 |
| 124 | MP0003635_abnormal_synaptic_transmissio | 1.00251711 |
| 125 | MP0004145_abnormal_muscle_electrophysio | 1.00247563 |
| 126 | MP0003567_abnormal_fetal_cardiomyocyte | 0.99317164 |
| 127 | MP0003632_abnormal_nervous_system | 0.99009581 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.98967923 |
| 129 | MP0003303_peritoneal_inflammation | 0.98918106 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.97925822 |
| 131 | MP0004215_abnormal_myocardial_fiber | 0.97866071 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.96631305 |
| 133 | MP0000371_diluted_coat_color | 0.95148318 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.95001465 |
| 135 | MP0000313_abnormal_cell_death | 0.94214977 |
| 136 | MP0001485_abnormal_pinna_reflex | 0.93581301 |
| 137 | MP0006276_abnormal_autonomic_nervous | 0.92056584 |
| 138 | MP0005448_abnormal_energy_balance | 0.91335874 |
| 139 | MP0001984_abnormal_olfaction | 0.91109413 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.91045761 |
| 141 | MP0001873_stomach_inflammation | 0.90675584 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.89268335 |
| 143 | MP0001324_abnormal_eye_pigmentation | 0.87915544 |
| 144 | MP0001986_abnormal_taste_sensitivity | 0.87818163 |
| 145 | MP0003950_abnormal_plasma_membrane | 0.87473030 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.87456001 |
| 147 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85889755 |
| 148 | MP0001970_abnormal_pain_threshold | 0.85662260 |
| 149 | MP0008789_abnormal_olfactory_epithelium | 0.85613673 |
| 150 | MP0003633_abnormal_nervous_system | 0.84637316 |
| 151 | MP0005367_renal/urinary_system_phenotyp | 0.84515284 |
| 152 | MP0000516_abnormal_urinary_system | 0.84515284 |
| 153 | MP0000647_abnormal_sebaceous_gland | 0.84410288 |
| 154 | MP0002733_abnormal_thermal_nociception | 0.83947592 |
| 155 | MP0003631_nervous_system_phenotype | 0.82087813 |
| 156 | MP0004133_heterotaxia | 0.81681746 |
| 157 | MP0001186_pigmentation_phenotype | 0.81450146 |
| 158 | MP0003448_altered_tumor_morphology | 0.80595517 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.79668628 |
| 160 | MP0006054_spinal_hemorrhage | 0.79446008 |
| 161 | MP0003943_abnormal_hepatobiliary_system | 0.78638808 |
| 162 | MP0002075_abnormal_coat/hair_pigmentati | 0.78592532 |
| 163 | MP0009278_abnormal_bone_marrow | 0.78056598 |
| 164 | MP0002102_abnormal_ear_morphology | 0.76763303 |
| 165 | MP0003119_abnormal_digestive_system | 0.73491251 |
| 166 | MP0000470_abnormal_stomach_morphology | 0.73110924 |
| 167 | MP0005395_other_phenotype | 0.72678318 |
| 168 | MP0008057_abnormal_DNA_replication | 0.72099205 |
| 169 | MP0002109_abnormal_limb_morphology | 0.71215205 |
| 170 | MP0000358_abnormal_cell_content/ | 0.70972244 |
| 171 | MP0002882_abnormal_neuron_morphology | 0.70934681 |
| 172 | MP0002229_neurodegeneration | 0.70499554 |
| 173 | MP0002751_abnormal_autonomic_nervous | 0.70161142 |
| 174 | MP0003866_abnormal_defecation | 0.69989369 |
| 175 | MP0000955_abnormal_spinal_cord | 0.69728968 |
| 176 | MP0002734_abnormal_mechanical_nocicepti | 0.68982858 |
| 177 | MP0004381_abnormal_hair_follicle | 0.68866122 |
| 178 | MP0009697_abnormal_copulation | 0.68723945 |
| 179 | MP0001879_abnormal_lymphatic_vessel | 0.68696126 |
| 180 | MP0008872_abnormal_physiological_respon | 0.68198052 |
| 181 | MP0005647_abnormal_sex_gland | 0.67387402 |
| 182 | MP0003880_abnormal_central_pattern | 0.67223273 |
| 183 | MP0002184_abnormal_innervation | 0.66907843 |
| 184 | MP0005167_abnormal_blood-brain_barrier | 0.66841104 |
| 185 | MP0004084_abnormal_cardiac_muscle | 0.64967973 |
| 186 | MP0005195_abnormal_posterior_eye | 0.64305327 |
| 187 | MP0001299_abnormal_eye_distance/ | 0.64100551 |
| 188 | MP0008775_abnormal_heart_ventricle | 0.64097253 |
| 189 | MP0000428_abnormal_craniofacial_morphol | 0.62087133 |
| 190 | MP0004085_abnormal_heartbeat | 0.61753442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 5.81769628 |
| 2 | Hyperventilation (HP:0002883) | 5.16902325 |
| 3 | Protruding tongue (HP:0010808) | 4.60479594 |
| 4 | Aplastic anemia (HP:0001915) | 4.57677341 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.19032992 |
| 6 | Pancreatic cysts (HP:0001737) | 4.15578808 |
| 7 | Recurrent abscess formation (HP:0002722) | 3.84258350 |
| 8 | Thrombocytosis (HP:0001894) | 3.80009556 |
| 9 | Gaze-evoked nystagmus (HP:0000640) | 3.79824377 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.68160031 |
| 11 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.62065425 |
| 12 | Pancreatic fibrosis (HP:0100732) | 3.57073859 |
| 13 | Myositis (HP:0100614) | 3.56805014 |
| 14 | Clumsiness (HP:0002312) | 3.43024102 |
| 15 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.40379567 |
| 16 | True hermaphroditism (HP:0010459) | 3.34778120 |
| 17 | Chronic otitis media (HP:0000389) | 3.33884072 |
| 18 | Fair hair (HP:0002286) | 3.30078528 |
| 19 | Exertional dyspnea (HP:0002875) | 3.29305521 |
| 20 | Reticulocytopenia (HP:0001896) | 3.24709484 |
| 21 | IgM deficiency (HP:0002850) | 3.23408678 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.21990070 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.17723072 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.16752520 |
| 25 | Chronic hepatic failure (HP:0100626) | 3.08235856 |
| 26 | Abnormality of the renal cortex (HP:0011035) | 3.07131657 |
| 27 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.05731739 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.05731739 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 3.02215077 |
| 30 | IgG deficiency (HP:0004315) | 3.00539342 |
| 31 | Febrile seizures (HP:0002373) | 2.95812298 |
| 32 | Dysmetric saccades (HP:0000641) | 2.94750094 |
| 33 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.92118575 |
| 34 | Increased intramyocellular lipid droplets (HP:0012240) | 2.84616618 |
| 35 | Cystic liver disease (HP:0006706) | 2.84287752 |
| 36 | Abnormal number of erythroid precursors (HP:0012131) | 2.81176826 |
| 37 | Obstructive lung disease (HP:0006536) | 2.80466973 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.80466973 |
| 39 | Increased serum lactate (HP:0002151) | 2.77720765 |
| 40 | Mitochondrial inheritance (HP:0001427) | 2.76833601 |
| 41 | Abnormality of the renal medulla (HP:0100957) | 2.75839161 |
| 42 | Hypothermia (HP:0002045) | 2.74824290 |
| 43 | Hypoplastic labia majora (HP:0000059) | 2.74499940 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73822862 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 2.73822862 |
| 46 | Hyperalaninemia (HP:0003348) | 2.73822862 |
| 47 | Broad-based gait (HP:0002136) | 2.72796912 |
| 48 | Lipid accumulation in hepatocytes (HP:0006561) | 2.71895351 |
| 49 | Nephronophthisis (HP:0000090) | 2.71883964 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.70634293 |
| 51 | Petechiae (HP:0000967) | 2.70449656 |
| 52 | Abnormality of midbrain morphology (HP:0002418) | 2.69973287 |
| 53 | Molar tooth sign on MRI (HP:0002419) | 2.69973287 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.69372886 |
| 55 | Increased CSF lactate (HP:0002490) | 2.69290242 |
| 56 | Generalized hypopigmentation of hair (HP:0011358) | 2.66926459 |
| 57 | Widely spaced teeth (HP:0000687) | 2.64222127 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.60495153 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.58957766 |
| 60 | Abnormality of the labia majora (HP:0012881) | 2.57672637 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.56889467 |
| 62 | Tubular atrophy (HP:0000092) | 2.54148689 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.53908624 |
| 64 | Absent speech (HP:0001344) | 2.53826112 |
| 65 | Patellar aplasia (HP:0006443) | 2.53788468 |
| 66 | Birth length less than 3rd percentile (HP:0003561) | 2.53771107 |
| 67 | Hepatic necrosis (HP:0002605) | 2.53126031 |
| 68 | Respiratory difficulties (HP:0002880) | 2.51085800 |
| 69 | Increased IgM level (HP:0003496) | 2.50791998 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.50691208 |
| 71 | Increased muscle lipid content (HP:0009058) | 2.50244691 |
| 72 | Gait imbalance (HP:0002141) | 2.42192994 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.41214488 |
| 74 | Drooling (HP:0002307) | 2.40805444 |
| 75 | Attenuation of retinal blood vessels (HP:0007843) | 2.38037079 |
| 76 | Orchitis (HP:0100796) | 2.37463190 |
| 77 | Recurrent fungal infections (HP:0002841) | 2.37277465 |
| 78 | Abnormality of the ischium (HP:0003174) | 2.37030658 |
| 79 | Congenital primary aphakia (HP:0007707) | 2.36754999 |
| 80 | Poor coordination (HP:0002370) | 2.36573986 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.32748655 |
| 82 | Hypoplastic ischia (HP:0003175) | 2.32592913 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.30764946 |
| 84 | Renal Fanconi syndrome (HP:0001994) | 2.30760087 |
| 85 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.29528721 |
| 86 | Optic nerve coloboma (HP:0000588) | 2.29152939 |
| 87 | Abnormality of the anterior horn cell (HP:0006802) | 2.28712887 |
| 88 | Degeneration of anterior horn cells (HP:0002398) | 2.28712887 |
| 89 | Abnormal protein glycosylation (HP:0012346) | 2.27718542 |
| 90 | Abnormal glycosylation (HP:0012345) | 2.27718542 |
| 91 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27718542 |
| 92 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27718542 |
| 93 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.24880841 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 2.23600642 |
| 95 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.22857361 |
| 96 | Type 2 muscle fiber atrophy (HP:0003554) | 2.22302839 |
| 97 | Preaxial foot polydactyly (HP:0001841) | 2.22094949 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 2.21543566 |
| 99 | Truncal obesity (HP:0001956) | 2.21153287 |
| 100 | Autoimmune thrombocytopenia (HP:0001973) | 2.19210976 |
| 101 | Excessive salivation (HP:0003781) | 2.18184997 |
| 102 | Inability to walk (HP:0002540) | 2.18134114 |
| 103 | Genital tract atresia (HP:0001827) | 2.17917118 |
| 104 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.17589757 |
| 105 | Recurrent viral infections (HP:0004429) | 2.15476302 |
| 106 | Vaginal atresia (HP:0000148) | 2.14832912 |
| 107 | Pallor (HP:0000980) | 2.14068610 |
| 108 | Decreased circulating renin level (HP:0003351) | 2.14038530 |
| 109 | Retrobulbar optic neuritis (HP:0100654) | 2.13760059 |
| 110 | Optic neuritis (HP:0100653) | 2.13760059 |
| 111 | Short foot (HP:0001773) | 2.13628447 |
| 112 | Abnormality of T cells (HP:0002843) | 2.13592580 |
| 113 | Poikiloderma (HP:0001029) | 2.12829460 |
| 114 | Meningitis (HP:0001287) | 2.12211148 |
| 115 | Congenital stationary night blindness (HP:0007642) | 2.11960803 |
| 116 | Vasculitis (HP:0002633) | 2.11846899 |
| 117 | Prolonged bleeding time (HP:0003010) | 2.11660271 |
| 118 | Volvulus (HP:0002580) | 2.11581236 |
| 119 | Absent radius (HP:0003974) | 2.11356959 |
| 120 | Progressive inability to walk (HP:0002505) | 2.11208911 |
| 121 | Dialeptic seizures (HP:0011146) | 2.10408023 |
| 122 | Lactic acidosis (HP:0003128) | 2.08394880 |
| 123 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05055204 |
| 124 | Poor head control (HP:0002421) | 2.04880780 |
| 125 | Recurrent skin infections (HP:0001581) | 2.03842978 |
| 126 | Congenital hepatic fibrosis (HP:0002612) | 2.03264593 |
| 127 | Furrowed tongue (HP:0000221) | 2.02931055 |
| 128 | Muscle fiber atrophy (HP:0100295) | 2.02499374 |
| 129 | Recurrent bronchitis (HP:0002837) | 2.01812577 |
| 130 | Panhypogammaglobulinemia (HP:0003139) | 2.01744562 |
| 131 | Exercise intolerance (HP:0003546) | 2.01178624 |
| 132 | Absent forearm bone (HP:0003953) | 1.99903478 |
| 133 | Aplasia involving forearm bones (HP:0009822) | 1.99903478 |
| 134 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98864712 |
| 135 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.98708227 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.97845674 |
| 137 | Cerebellar dysplasia (HP:0007033) | 1.96796915 |
| 138 | Large for gestational age (HP:0001520) | 1.96218571 |
| 139 | Tubulointerstitial nephritis (HP:0001970) | 1.95633617 |
| 140 | Blue irides (HP:0000635) | 1.95454538 |
| 141 | Tracheomalacia (HP:0002779) | 1.94119276 |
| 142 | Macroglossia (HP:0000158) | 1.93640488 |
| 143 | Short chin (HP:0000331) | 1.93406785 |
| 144 | Pancytopenia (HP:0001876) | 1.93010199 |
| 145 | Progressive macrocephaly (HP:0004481) | 1.92985215 |
| 146 | Hypoplasia of the thymus (HP:0000778) | 1.91731628 |
| 147 | Cupped ear (HP:0000378) | 1.91511248 |
| 148 | Abnormality of the nasal septum (HP:0000419) | 1.90882775 |
| 149 | Absence seizures (HP:0002121) | 1.90829648 |
| 150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88334513 |
| 151 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88334513 |
| 152 | 3-Methylglutaconic aciduria (HP:0003535) | 1.87908285 |
| 153 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.87816309 |
| 154 | Stomach cancer (HP:0012126) | 1.87425447 |
| 155 | Central scotoma (HP:0000603) | 1.87084099 |
| 156 | Clubbing of toes (HP:0100760) | 1.86115264 |
| 157 | Lymphopenia (HP:0001888) | 1.84958867 |
| 158 | Lissencephaly (HP:0001339) | 1.84908042 |
| 159 | Focal seizures (HP:0007359) | 1.84804895 |
| 160 | Hyperkalemia (HP:0002153) | 1.84660161 |
| 161 | Preaxial hand polydactyly (HP:0001177) | 1.83521046 |
| 162 | Tented upper lip vermilion (HP:0010804) | 1.83478192 |
| 163 | Metaphyseal dysplasia (HP:0100255) | 1.82839869 |
| 164 | Macrocytic anemia (HP:0001972) | 1.82358391 |
| 165 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82125837 |
| 166 | Encephalitis (HP:0002383) | 1.81785359 |
| 167 | Renal cortical cysts (HP:0000803) | 1.81066543 |
| 168 | Abnormality of the fingertips (HP:0001211) | 1.80943666 |
| 169 | Highly arched eyebrow (HP:0002553) | 1.80795142 |
| 170 | Hypoproteinemia (HP:0003075) | 1.80640752 |
| 171 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80308337 |
| 172 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.80304687 |
| 173 | Severe visual impairment (HP:0001141) | 1.79639743 |
| 174 | Bronchomalacia (HP:0002780) | 1.79422840 |
| 175 | Neoplasm of the adrenal gland (HP:0100631) | 1.79096530 |
| 176 | Impaired smooth pursuit (HP:0007772) | 1.78976939 |
| 177 | Lymphoma (HP:0002665) | 1.77594932 |
| 178 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77246192 |
| 179 | Atonic seizures (HP:0010819) | 1.76674797 |
| 180 | Abnormality of the axillary hair (HP:0100134) | 1.75061285 |
| 181 | Abnormality of secondary sexual hair (HP:0009888) | 1.75061285 |
| 182 | Osteomyelitis (HP:0002754) | 1.74172541 |
| 183 | Anencephaly (HP:0002323) | 1.73720593 |
| 184 | Severe combined immunodeficiency (HP:0004430) | 1.73318800 |
| 185 | Spontaneous hematomas (HP:0007420) | 1.72968653 |
| 186 | Thyroiditis (HP:0100646) | 1.71968859 |
| 187 | Hypoplastic iliac wings (HP:0002866) | 1.71404611 |
| 188 | Chronic sinusitis (HP:0011109) | 1.71257599 |
| 189 | Neutropenia (HP:0001875) | 1.71219613 |
| 190 | Thick eyebrow (HP:0000574) | 1.70456020 |
| 191 | Bulbous nose (HP:0000414) | 1.70302642 |
| 192 | Abnormality of incisor morphology (HP:0011063) | 1.68567577 |
| 193 | Small hand (HP:0200055) | 1.66595298 |
| 194 | Absent/shortened dynein arms (HP:0200106) | 1.66566757 |
| 195 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.66566757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.35259895 |
| 2 | STK16 | 3.22559961 |
| 3 | EIF2AK1 | 3.05735773 |
| 4 | AKT3 | 2.95592465 |
| 5 | NME2 | 2.90884613 |
| 6 | BUB1 | 2.71477245 |
| 7 | ERBB3 | 2.34078511 |
| 8 | BLK | 2.31225499 |
| 9 | TAOK2 | 2.25627374 |
| 10 | MKNK2 | 2.23510307 |
| 11 | PIM2 | 2.18907784 |
| 12 | SIK3 | 2.14295889 |
| 13 | KIT | 2.10641082 |
| 14 | CASK | 2.01389597 |
| 15 | CDK19 | 2.01029736 |
| 16 | FRK | 10.0413194 |
| 17 | TXK | 1.90478870 |
| 18 | CCNB1 | 1.86514382 |
| 19 | JAK3 | 1.80989811 |
| 20 | CAMK1G | 1.80288936 |
| 21 | MAP3K14 | 1.79083093 |
| 22 | TBK1 | 1.78321803 |
| 23 | TGFBR1 | 1.74848403 |
| 24 | IRAK4 | 1.71287318 |
| 25 | BRD4 | 1.70542262 |
| 26 | CAMK1D | 1.69530894 |
| 27 | CDK12 | 1.69261151 |
| 28 | MAP4K1 | 1.66665429 |
| 29 | KDR | 1.64750607 |
| 30 | INSRR | 1.62538773 |
| 31 | ZAP70 | 1.61514946 |
| 32 | MAP3K4 | 1.58779802 |
| 33 | MYLK | 1.55014869 |
| 34 | ACVR1B | 1.54818943 |
| 35 | TEC | 1.50947800 |
| 36 | PBK | 1.42615400 |
| 37 | EIF2AK2 | 1.41914661 |
| 38 | TESK1 | 1.37900361 |
| 39 | ADRBK2 | 1.33267249 |
| 40 | NEK1 | 1.32989907 |
| 41 | WEE1 | 1.32422464 |
| 42 | FLT3 | 1.31541235 |
| 43 | TYK2 | 1.30827383 |
| 44 | DAPK1 | 1.29876793 |
| 45 | TAOK3 | 1.29822190 |
| 46 | OXSR1 | 1.28336162 |
| 47 | SGK2 | 1.28333002 |
| 48 | RPS6KA4 | 1.24118475 |
| 49 | DYRK2 | 1.23495679 |
| 50 | BTK | 1.23329891 |
| 51 | VRK1 | 1.20553734 |
| 52 | LATS1 | 1.19491460 |
| 53 | IKBKE | 1.18294671 |
| 54 | EIF2AK3 | 1.17803985 |
| 55 | STK38L | 1.17006073 |
| 56 | SYK | 1.16964867 |
| 57 | TRPM7 | 1.16164246 |
| 58 | SCYL2 | 1.14161150 |
| 59 | CDC7 | 1.12751430 |
| 60 | MAP2K3 | 1.12740960 |
| 61 | ADRBK1 | 1.11809347 |
| 62 | WNK3 | 1.09571755 |
| 63 | GRK1 | 1.08598196 |
| 64 | PIK3CA | 1.05896778 |
| 65 | SRPK1 | 1.00678470 |
| 66 | NTRK3 | 1.00207168 |
| 67 | STK39 | 0.99833213 |
| 68 | MELK | 0.99614320 |
| 69 | TLK1 | 0.97744324 |
| 70 | PIK3CG | 0.97703844 |
| 71 | LYN | 0.96214610 |
| 72 | MAP3K11 | 0.96024036 |
| 73 | MAP2K7 | 0.95848196 |
| 74 | NUAK1 | 0.90796249 |
| 75 | MAP3K7 | 0.90699182 |
| 76 | STK3 | 0.90623795 |
| 77 | IKBKB | 0.90026036 |
| 78 | PNCK | 0.88405301 |
| 79 | MARK1 | 0.87775730 |
| 80 | YES1 | 0.84193587 |
| 81 | MAP3K5 | 0.83379585 |
| 82 | PAK3 | 0.83336828 |
| 83 | WNK4 | 0.82758636 |
| 84 | BRAF | 0.82542757 |
| 85 | TESK2 | 0.82203087 |
| 86 | DAPK2 | 0.81047182 |
| 87 | WNK1 | 0.80955734 |
| 88 | PIM1 | 0.80622215 |
| 89 | PRKAA2 | 0.80286130 |
| 90 | BMPR1B | 0.80245373 |
| 91 | CDK8 | 0.80237627 |
| 92 | DYRK3 | 0.79558730 |
| 93 | FGFR2 | 0.79476031 |
| 94 | TNIK | 0.77969553 |
| 95 | NEK9 | 0.77645529 |
| 96 | SGK494 | 0.76611953 |
| 97 | SGK223 | 0.76611953 |
| 98 | STK24 | 0.73617814 |
| 99 | LRRK2 | 0.70389245 |
| 100 | CSF1R | 0.68970666 |
| 101 | MKNK1 | 0.66944785 |
| 102 | PAK4 | 0.66670694 |
| 103 | PRKCE | 0.66022470 |
| 104 | SGK3 | 0.65540648 |
| 105 | EPHA3 | 0.64647738 |
| 106 | RIPK4 | 0.63313275 |
| 107 | LCK | 0.61546479 |
| 108 | STK38 | 0.61403451 |
| 109 | ABL2 | 0.61301582 |
| 110 | FER | 0.61135522 |
| 111 | ZAK | 0.60256702 |
| 112 | PASK | 0.59917082 |
| 113 | CDK7 | 0.59559201 |
| 114 | CHUK | 0.59355125 |
| 115 | IRAK1 | 0.59072850 |
| 116 | NEK2 | 0.58863516 |
| 117 | CLK1 | 0.57323804 |
| 118 | ERBB2 | 0.56015791 |
| 119 | CSNK1A1L | 0.55870339 |
| 120 | MAP4K2 | 0.55604560 |
| 121 | STK11 | 0.55401179 |
| 122 | BRSK2 | 0.55273756 |
| 123 | ERN1 | 0.55243807 |
| 124 | CAMK4 | 0.55015385 |
| 125 | NLK | 0.54943387 |
| 126 | ATR | 0.53853110 |
| 127 | MAP2K6 | 0.52824519 |
| 128 | PRKAA1 | 0.52697934 |
| 129 | PTK2B | 0.52666364 |
| 130 | MAP3K8 | 0.51625294 |
| 131 | PDGFRB | 0.51396093 |
| 132 | PRKCD | 0.51360313 |
| 133 | OBSCN | 0.50422170 |
| 134 | CAMK1 | 0.49714307 |
| 135 | DAPK3 | 0.48512094 |
| 136 | SGK1 | 0.48015991 |
| 137 | MAPK13 | 0.46888966 |
| 138 | FES | 0.46857380 |
| 139 | IRAK3 | 0.46688439 |
| 140 | MAPK4 | 0.45472264 |
| 141 | JAK1 | 0.45297926 |
| 142 | PRKCG | 0.44990584 |
| 143 | ILK | 0.44751120 |
| 144 | STK10 | 0.43580343 |
| 145 | MARK2 | 0.42362832 |
| 146 | CDK3 | 0.41662691 |
| 147 | CSNK1D | 0.41632746 |
| 148 | MATK | 0.40774263 |
| 149 | MAPK11 | 0.40623993 |
| 150 | CAMKK2 | 0.39545371 |
| 151 | CSNK2A1 | 0.38210261 |
| 152 | PINK1 | 0.37514048 |
| 153 | MAP2K4 | 0.37254285 |
| 154 | MTOR | 0.36639134 |
| 155 | TIE1 | 0.35333952 |
| 156 | SIK2 | 0.35079076 |
| 157 | PLK2 | 0.34674625 |
| 158 | PKN1 | 0.33390366 |
| 159 | MAPK7 | 0.32837880 |
| 160 | ATM | 0.32728700 |
| 161 | STK4 | 0.32617719 |
| 162 | EPHA4 | 0.32530075 |
| 163 | RPS6KA3 | 0.30725671 |
| 164 | GSK3B | 0.30439247 |
| 165 | MAPK8 | 0.29826158 |
| 166 | CAMK2A | 0.29799919 |
| 167 | DYRK1A | 0.29743337 |
| 168 | PRKCH | 0.29645718 |
| 169 | FGFR3 | 0.28902416 |
| 170 | CHEK2 | 0.28486844 |
| 171 | RPS6KA6 | 0.27381785 |
| 172 | PRKG1 | 0.26782162 |
| 173 | PRKACB | 0.26630906 |
| 174 | MAP3K6 | 0.26373780 |
| 175 | TNK2 | 0.25011011 |
| 176 | BCR | 0.23908960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.67411588 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.58426251 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.51687910 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.69410440 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.59301182 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.50544981 |
| 7 | ABC transporters_Homo sapiens_hsa02010 | 2.35780150 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.35455493 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.33491381 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.18895597 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.14013165 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.97138693 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 1.96689813 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87192466 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86423629 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.84204756 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 1.81958650 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.81554464 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79782523 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.71521720 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.67472539 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66928178 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64206149 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.64103271 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.62902590 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.62307051 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58303729 |
| 28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.57693339 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56975780 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56809950 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.56107041 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.55594737 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.55057555 |
| 34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54950540 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54924326 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52417543 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51932310 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 1.51369733 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.49636751 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47311113 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47175399 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.44820099 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43577919 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42681584 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32670517 |
| 46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.29755439 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.28812056 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.28471332 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.27602110 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24316534 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22687715 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22135784 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.21291079 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 1.20546828 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20192941 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 1.19341709 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18339824 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18029420 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16080807 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15695732 |
| 61 | RNA transport_Homo sapiens_hsa03013 | 1.14860259 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 1.14586766 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14502733 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 1.13961956 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13713740 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 1.11287518 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 1.10296805 |
| 68 | Purine metabolism_Homo sapiens_hsa00230 | 1.10230371 |
| 69 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09456747 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09218090 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.08571966 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.08225022 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07627579 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07623209 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06517883 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 1.06498599 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04154323 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02040608 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01252483 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.99772391 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99308209 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98716358 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98020582 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97336864 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.95435632 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95090112 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.94218866 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.93371720 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92029486 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.91892577 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91221417 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90999707 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90866666 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.89568758 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.88402117 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88278576 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87990637 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.87737883 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87513533 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87167896 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87071827 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85744017 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85351470 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85323211 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85106264 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83636773 |
| 107 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83559923 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82845316 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81691639 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81535680 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81426917 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80743515 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.80416237 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80222517 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79437341 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79351283 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79083334 |
| 118 | Platelet activation_Homo sapiens_hsa04611 | 0.78866535 |
| 119 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78697705 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78663195 |
| 121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.78519659 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77586743 |
| 123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.75792998 |
| 124 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.75135965 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74421280 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73087631 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71961832 |
| 128 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69602762 |
| 129 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69506590 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.69409401 |
| 131 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69080403 |
| 132 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68583912 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67037335 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65919427 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65503534 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65383429 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65359803 |
| 138 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65030952 |
| 139 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64833883 |
| 140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63156118 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62907682 |
| 142 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.62778013 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61851463 |
| 144 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61689347 |
| 145 | Melanoma_Homo sapiens_hsa05218 | 0.61314647 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61005850 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60945064 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60671810 |
| 149 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60357361 |
| 150 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60015902 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59990700 |
| 152 | Sulfur relay system_Homo sapiens_hsa04122 | 0.56511243 |
| 153 | Salmonella infection_Homo sapiens_hsa05132 | 0.55400297 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55278928 |
| 155 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55244460 |
| 156 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.55216768 |
| 157 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54138686 |
| 158 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.54046117 |
| 159 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53815790 |
| 160 | Insulin resistance_Homo sapiens_hsa04931 | 0.52644474 |
| 161 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52496944 |
| 162 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51596946 |
| 163 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51402802 |
| 164 | Axon guidance_Homo sapiens_hsa04360 | 0.51307262 |
| 165 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50303649 |
| 166 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50302682 |
| 167 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50175364 |
| 168 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50020564 |
| 169 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49416476 |
| 170 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49002929 |
| 171 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47999993 |
| 172 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47503881 |
| 173 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46788992 |
| 174 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46132139 |
| 175 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45808282 |
| 176 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45441858 |
| 177 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45178624 |
| 178 | Bile secretion_Homo sapiens_hsa04976 | 0.45096050 |
| 179 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43696756 |
| 180 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43444751 |
| 181 | Hepatitis C_Homo sapiens_hsa05160 | 0.43219959 |
| 182 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42235504 |
| 183 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39738318 |
| 184 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38569874 |
| 185 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34781213 |
| 186 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34119273 |
| 187 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32102931 |
| 188 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31861227 |
| 189 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31745705 |
| 190 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31415423 |

